Literature DB >> 14710291

A case of rifampicin induced pseudomembraneous colitis.

Daad H Akbar1, Halia Z Al-Shehri, Amani M Al-Huzali, Hind I Falatah.   

Abstract

We report a case pf pseudomembranous colitis that developed in a patient with tuberculous abdominal lymphadenopathy during treatment with rifampicin. The patient had delayed presentation (3 months) after the start of rifampicin. She had one relapse after 2 months that was successfully treated, and she finished her antituberculosis therapy without any further relapses. Awareness of this serious complication of rifampicin therapy should be encountered.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14710291

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  3 in total

1.  Localized pseudomembranous colitis in the cecum and ascending colon mimicking acute appendicitis.

Authors:  Ju Won Chyung; Dong Gue Shin
Journal:  World J Gastrointest Surg       Date:  2013-05-27

2.  Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation.

Authors:  Jie Cheng; Yatrik M Shah; Xiaochao Ma; Xiaoyan Pang; Toshiya Tanaka; Tatsuhiko Kodama; Kristopher W Krausz; Frank J Gonzalez
Journal:  J Pharmacol Exp Ther       Date:  2010-07-13       Impact factor: 4.030

3.  Rifampin-induced Pseudomembranous Colitis with Rectosigmoid Sparing.

Authors:  Sun Young Yim; Ja Seol Koo; Ye Ji Kim; Sang Jung Park; Jin Nam Kim; Sung Woo Jung; Hyung Joon Yim; Sang Woo Lee; Jai Hyun Choi; Chang Duck Kim
Journal:  Clin Endosc       Date:  2011-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.